Business Context and Reporting Period
This Form 10-K is a combined annual report for Corteva, Inc. (CTVA) and its wholly-owned subsidiary, EIDP, Inc. (formerly E. I. du Pont de Nemours and Company), for the fiscal year ended December 31, 2025. Corteva is a leading global provider of seed and crop protection solutions. EIDP operates as a subsidiary holding company, with its primary financial differences from Corteva relating to preferred stock, related-party loans, and intercompany dividends. On October 1, 2025, Corteva announced its intent to separate its Seed and Crop Protection businesses into two standalone, publicly traded companies via a tax-free spin-off, targeted for the second half of 2026.
Key Financial Metrics (2025)
| Metric | 2025 Value | 2024 Value |
|---|---|---|
| Net Sales | $17,401 million | $16,908 million |
| Income from Continuing Operations (After Tax) | $1,204 million | $863 million |
| Net Income (Attributable to Corteva) | $1,094 million | $907 million |
| Operating EBITDA (Non-GAAP) | $3,848 million | $3,376 million |
| Free Cash Flow (Non-GAAP) | $2,866 million | $1,699 million |
| Total Debt | $2,580 million | $2,703 million |
| Cash, Cash Equivalents & Marketable Securities | $4,530 million | $3,169 million |
| Effective Tax Rate | 28.7% | 32.3% |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 3% year-over-year, driven by a 1% price increase and 3% volume growth, partially offset by a 1% unfavorable currency impact. Seed sales grew 4% and Crop Protection sales grew 2%.
- Profitability: Income from continuing operations rose 40% to $1.204 billion. Operating EBITDA increased 14% to $3.848 billion, aided by volume growth, favorable Seed pricing, and cost productivity actions.
- Cost of Goods Sold (COGS): COGS decreased to $9.172 billion (53% of sales) from $9.529 billion (56% of sales) in 2024, driven by raw material deflation, lower commodity prices, and reduced royalty expenses.
- Restructuring: Restructuring and asset-related charges decreased to $146 million from $288 million in 2024. The company continues the "Crop Protection Operations Strategy Restructuring Program," with $611 million recorded inception-to-date.
- Significant Items: A $610 million charge was recorded in 2025 related to the resolution of litigation with Bayer, which was offset by insurance proceeds and other benefits.
- Discontinued Operations: The company reported a loss of $99 million from discontinued operations, primarily due to PFAS environmental remediation activities and the NJ Statewide Settlement.
Guidance, Outlook, and Risks
- Proposed Separation: Corteva plans to spin off its Seed and Crop Protection businesses into two independent public companies in H2 2026. The transaction is intended to be tax-free. Management expects the separation to require significant time and attention, potentially disrupting ongoing business.
- Capital Allocation: The company returned approximately $1.5 billion to shareholders in 2025 via dividends and share repurchases. A $3 billion share repurchase program was authorized in late 2024, with $571 million utilized in 2025. The quarterly dividend was increased to $0.18 per share.
- Key Risks:
- Regulatory: Delays or failures in obtaining regulatory approvals for biotechnology traits and crop protection products could restrict market access.
- Environmental & Litigation: Significant exposure remains regarding legacy PFAS liabilities (shared with Chemours and DuPont) and ongoing litigation (e.g., Lorsban, antitrust investigations by the FTC).
- Geopolitical: Conflicts (e.g., Russia-Ukraine, China-Taiwan) and trade barriers could disrupt supply chains and increase input costs.
- Weather & Climate: Unpredictable weather patterns and climate change impact planting seasons, crop yields, and demand for crop protection products.
Investor Verification Checklist
- Separation Timeline: Verify the progress of the proposed Seed/Crop Protection spin-off and potential impacts on capital structure and debt allocation.
- Bayer Litigation Resolution: Confirm the final terms of the $610 million settlement and the cessation of royalty obligations for Enlist E3 soybeans.
- PFAS Liability Exposure: Review the status of the NJ Statewide Settlement ($875 million aggregate payment) and the MOU Escrow Account funding obligations with Chemours and DuPont.
- Antitrust Investigations: Monitor the status of the FTC and state attorney general lawsuits regarding anticompetitive conduct in the Crop Protection segment.
- Valuation Allowances: Assess the impact of the $132 million valuation allowance established against deferred tax assets in Brazil.